Related Experiment Video
Updated: Mar 18, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma
Juan Chai1, Jun Ju1, Shao-Wu Zhang2
1State Key Laboratory of Military Stomatology, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Abstract:
p12 cyclin-dependent kinase 2 (CDK2)-associating protein 1 (p12CDK2-AP1) has been demonstrated to negatively regulate the activity of CDK2. However, the underlying molecular mechanism remains largely unknown. We aimed to determine the potential binding proteins of p12CDK2-AP1 and to elucidate the role of p12CDK2-AP1 in the regulation of the proliferation, invasion, apoptosis, and in vivo growth of human oral squamous cell carcinoma cells. The protein-protein interaction was predicted using computational decision templates. The predicted p12CDK2‑AP1 interacting proteins were overexpressed in human oral squamous cell carcinoma OSCC-15 cells, and the protein binding was examined using co-precipitation (Co-IP). Cell proliferation and invasion were determined via MTT assay and Transwell system, respectively. Cell apoptosis was evaluated using Annexin V-FITC/PI double staining followed by flow cytometric analysis. The in vivo growth of OSCC-15 cells was examined in nude mouse tumor xenografts. We found that overexpression of either p12CDK2-AP1 or CD82 significantly suppressed the proliferation and invasion but promoted the apoptosis of OSCC-15 cells (P<0.05). Importantly, combined overexpression of p12CDK2-AP1 and CD82 showed synergistic antitumor activity compared with the overexpression of a single protein alone (P<0.05). Additionally, the simultaneous overexpression of p12CDK2-AP1 and CD82 significantly suppressed the in vivo tumor growth of OSCC-15 cells in nude mice compared with the negative control (P<0.05). Our findings indicate that p12CDK2-AP1 interacts with CD82 to play a functional role in suppressing the in vitro and in vivo growth of OSCC-15 cells.
Insights
p12 cyclin-dependent kinase 2 (CDK2)-associating protein 1 (p12CDK2-AP1) interacts with CD82 to suppress oral cancer cell growth. Combined overexpression of both proteins shows synergistic antitumor effects in vitro and in vivo.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- p12 cyclin-dependent kinase 2 (CDK2)-associating protein 1 (p12CDK2-AP1) is known to inhibit CDK2 activity, but its precise molecular mechanism and role in cancer are not fully understood.
- Understanding p12CDK2-AP1's interactions is crucial for elucidating its function in cellular processes relevant to cancer progression.
Purpose of the Study:
- To identify binding proteins of p12CDK2-AP1.
- To investigate the role of p12CDK2-AP1 in regulating the proliferation, invasion, and apoptosis of human oral squamous cell carcinoma (OSCC) cells.
- To evaluate the combined effect of p12CDK2-AP1 and its binding partner on OSCC growth both in vitro and in vivo.
Main Methods:
- Computational prediction of protein-protein interactions.
- Overexpression of p12CDK2-AP1 and CD82 in OSCC-15 cells.
- Co-immunoprecipitation (Co-IP) to confirm protein binding.
- MTT assay for proliferation, Transwell system for invasion, and Annexin V-FITC/PI staining for apoptosis.
- In vivo tumor xenograft models in nude mice.
Main Results:
- Overexpression of p12CDK2-AP1 or CD82 individually suppressed OSCC cell proliferation and invasion while promoting apoptosis.
- Combined overexpression of p12CDK2-AP1 and CD82 demonstrated synergistic antitumor activity compared to single protein overexpression.
- Simultaneous overexpression of p12CDK2-AP1 and CD82 significantly inhibited in vivo tumor growth in nude mice.
Conclusions:
- p12CDK2-AP1 interacts with CD82.
- This interaction plays a significant role in suppressing the in vitro and in vivo growth of human oral squamous cell carcinoma cells.
- The combined overexpression of p12CDK2-AP1 and CD82 exhibits potent synergistic antitumor effects, suggesting therapeutic potential.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
Positive Regulator Molecules
Positive Regulator Molecules